BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dos Santos MCT, Scheller D, Schulte C, Mesa IR, Colman P, Bujac SR, Bell R, Berteau C, Perez LT, Lachmann I, Berg D, Maetzler W, Nogueira da Costa A. Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis. PLoS One 2018;13:e0206536. [PMID: 30383831 DOI: 10.1371/journal.pone.0206536] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Gibson R, Dalvi SP, Dalvi PS. DJ-1 and Parkinson's disease. Brain Disorders 2021;3:100020. [DOI: 10.1016/j.dscb.2021.100020] [Reference Citation Analysis]
2 Sampedro F, Marín‐lahoz J, Martínez‐horta S, Pérez‐gonzález R, Pagonabarraga J, Kulisevsky J. CLU rs11136000 Promotes Early Cognitive Decline in Parkinson's Disease. Mov Disord 2020;35:508-13. [DOI: 10.1002/mds.27949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Cheslow L, Snook AE, Waldman SA. Emerging targets for the diagnosis of Parkinson's disease: examination of systemic biomarkers. Biomark Med 2021;15:597-608. [PMID: 33988462 DOI: 10.2217/bmm-2020-0654] [Reference Citation Analysis]
4 Huang M, Chen S. DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application. Prog Neurobiol 2021;204:102114. [PMID: 34174373 DOI: 10.1016/j.pneurobio.2021.102114] [Reference Citation Analysis]
5 Zhu S, Wuolikainen A, Wu J, Öhman A, Wingsle G, Moritz T, Andersen PM, Forsgren L, Trupp M. Targeted Multiple Reaction Monitoring Analysis of CSF Identifies UCHL1 and GPNMB as Candidate Biomarkers for ALS. J Mol Neurosci 2019;69:643-57. [PMID: 31721001 DOI: 10.1007/s12031-019-01411-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hassan Q, Li S, Ferrag C, Kerman K. Electrochemical biosensors for the detection and study of α-synuclein related to Parkinson's disease - A review. Anal Chim Acta 2019;1089:32-9. [PMID: 31627816 DOI: 10.1016/j.aca.2019.09.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
7 Hor SL, Teoh SL, Lim WL. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress. Curr Drug Targets 2020;21:458-76. [PMID: 31625473 DOI: 10.2174/1389450120666191017120505] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
8 Angelopoulou E, Paudel YN, Piperi C. Emerging role of S100B protein implication in Parkinson's disease pathogenesis. Cell Mol Life Sci 2021;78:1445-53. [PMID: 33052436 DOI: 10.1007/s00018-020-03673-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Mei J, Desrosiers C, Frasnelli J. Machine Learning for the Diagnosis of Parkinson's Disease: A Review of Literature. Front Aging Neurosci 2021;13:633752. [PMID: 34025389 DOI: 10.3389/fnagi.2021.633752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Du T, Wang L, Liu W, Zhu G, Chen Y, Zhang J. Biomarkers and the Role of α-Synuclein in Parkinson's Disease. Front Aging Neurosci 2021;13:645996. [PMID: 33833675 DOI: 10.3389/fnagi.2021.645996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Luna-Herrera C, Martínez-Dávila IA, Soto-Rojas LO, Flores-Martinez YM, Fernandez-Parrilla MA, Ayala-Davila J, León-Chavez BA, Soto-Rodriguez G, Blanco-Alvarez VM, Lopez-Salas FE, Gutierrez-Castillo ME, Gatica-Garcia B, Padilla-Viveros A, Bañuelos C, Reyes-Corona D, Espadas-Alvarez AJ, Garcés-Ramírez L, Hidalgo-Alegria O, De La Cruz-López F, Martinez-Fong D. Intranigral Administration of β-Sitosterol-β-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra. J Immunol Res 2020;2020:5907591. [PMID: 33282962 DOI: 10.1155/2020/5907591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Sarkar A, Rawat N, Sachan N, Singh MP. Unequivocal Biomarker for Parkinson’s Disease: A Hunt that Remains a Pester. Neurotox Res 2019;36:627-44. [DOI: 10.1007/s12640-019-00080-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Konjevod M, Sáiz J, Barbas C, Bergareche A, Ardanaz E, Huerta JM, Vinagre-aragón A, Erro ME, Chirlaque MD, Abilleira E, Ibarluzea JM, Amiano P. A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease. Front Neurol 2022;13:844841. [DOI: 10.3389/fneur.2022.844841] [Reference Citation Analysis]
14 Ryan E, Seehra G, Sharma P, Sidransky E. GBA1-associated parkinsonism: new insights and therapeutic opportunities. Curr Opin Neurol 2019;32:589-96. [PMID: 31188151 DOI: 10.1097/WCO.0000000000000715] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
15 Ujcikova H, Eckhardt A, Hejnova L, Novotny J, Svoboda P. Alterations in the Proteome and Phosphoproteome Profiles of Rat Hippocampus after Six Months of Morphine Withdrawal: Comparison with the Forebrain Cortex. Biomedicines 2022;10:80. [DOI: 10.3390/biomedicines10010080] [Reference Citation Analysis]
16 Shu Z, Pang P, Wu X, Cui S, Xu Y, Zhang M. An Integrative Nomogram for Identifying Early-Stage Parkinson's Disease Using Non-motor Symptoms and White Matter-Based Radiomics Biomarkers From Whole-Brain MRI. Front Aging Neurosci 2020;12:548616. [PMID: 33390927 DOI: 10.3389/fnagi.2020.548616] [Reference Citation Analysis]
17 Repici M, Giorgini F. DJ-1 in Parkinson's Disease: Clinical Insights and Therapeutic Perspectives. J Clin Med 2019;8:E1377. [PMID: 31484320 DOI: 10.3390/jcm8091377] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
18 Bell R, Vendruscolo M. Modulation of the Interactions Between α-Synuclein and Lipid Membranes by Post-translational Modifications. Front Neurol 2021;12:661117. [PMID: 34335440 DOI: 10.3389/fneur.2021.661117] [Reference Citation Analysis]
19 Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease. Nanoneuroprotection and Nanoneurotoxicology. Elsevier; 2019. pp. 201-46. [DOI: 10.1016/bs.pbr.2019.03.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]